Details
CJC-1295 No DAC + Ipamorelin Blend (5mg / 5mg) – Synergistic Growth Hormone Secretagogue
Optimize growth hormone release pathways with this 1:1 synergistic peptide blend combining 5mg of CJC-1295 (without DAC) and 5mg of Ipamorelin (10mg total peptide per vial). CJC-1295 acts as a Growth Hormone-Releasing Hormone (GHRH) analog, while Ipamorelin acts as a selective Ghrelin/Growth Hormone Secretagogue Receptor (GHSR) agonist. Together, they stimulate natural, pulsatile growth hormone secretion without significant spikes in cortisol or prolactin.
Key Benefits & Ideal For
Key Benefits:
- Synergistic GH Release: Dual-receptor activation amplifies natural growth hormone pulses far beyond individual administration.
- Supports Muscle Repair & Recovery: Enhances protein synthesis and accelerates tissue recovery after exertion.
- Promotes Fat Metabolism: Supports lipolysis and improved body composition parameters.
- High Selectivity & Safety Profile: Minimizes off-target elevation of aldosterone, cortisol, or prolactin.
Ideal For:
- Growth hormone pathway optimization research
- Recovery and cellular repair modeling
- Body composition and lipolysis studies
- Anti-aging and pituitary signaling research
Dosing Protocol
Typical research dosing ranges from 100 mcg to 300 mcg of total blend per administration (usually 1 to 2 times daily, ideally on an empty stomach).
Reconstitution Guidance
Add 2mL of bacteriostatic water to get a solution containing 5mg/mL total blended peptide (2.5mg CJC / 2.5mg Ipamorelin per mL), such that every 0.1mL (10 units on an insulin syringe) delivers 500mcg of total blended peptide (250mcg CJC-1295 / 250mcg Ipamorelin).
Storage & Handling
Store unmixed vials in a cool, dark place away from direct light. Once reconstituted, this product must be refrigerated between 2°C – 8°C (36°F – 46°F) and used within 30 days.
